Cargando…

Increased Magnetic Susceptibility in the Deep Gray Matter Nuclei of Wilson's Disease: Have We Been Ignoring Atrophy?

BACKGROUND: Histopathological studies in Wilson's disease (WD) have revealed increased copper and iron concentrations in the deep gray matter nuclei. However, the commonly used mean bulk susceptibility only reflects the regional metal concentration rather than the total metal content, and regio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jing, Xiao-Zhong, Yuan, Xiang-Zhen, Li, Gai-Ying, Chen, Jia-Lin, Wu, Rong, Yang, Ling-Li, Zhang, Shu-Yun, Wang, Xiao-Ping, Li, Jian-Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198485/ https://www.ncbi.nlm.nih.gov/pubmed/35720701 http://dx.doi.org/10.3389/fnins.2022.794375

Ejemplares similares

Paramagnetic Metal Accumulation in the Deep Gray Matter Nuclei Is Associated With Neurodegeneration in Wilson’s Disease
por: Yuan, Xiang-Zhen, et al.
Publicado: (2020)

Pulmonary function in patients with spinal deformity: have we been ignorant?
por: Van Hooff, Miranda L, et al.
Publicado: (2020)

THE STRENGTH OF WEAKER TIES: HAVE WE BEEN IGNORING A RESOURCE FOR AGING ADULTS?
por: Fiori, Katherine L, et al.
Publicado: (2019)

Agent Orange: Haft-Century Effects On The Vietnamese Wildlife Have Been Ignored
por: Truong, Kiem N., et al.
Publicado: (2021)

We have been warned
Publicado: (2003)

Gray matter imaging in multiple sclerosis: what have we learned?
por: Hulst, Hanneke E, et al.
Publicado: (2011)

Have we been operating safely in 2015?
por: Wollmann, D, et al.
Publicado: (2016)

Is Cenobamate the Breakthrough We Have Been Wishing for?
por: Specchio, Nicola, et al.
Publicado: (2021)

Atrophy in subcortical gray matter in adult patients with moyamoya disease
por: Zuo, Zhiwei, et al.
Publicado: (2023)

CAU-Net: A Deep Learning Method for Deep Gray Matter Nuclei Segmentation
por: Chai, Chao, et al.
Publicado: (2022)

Regional Gray Matter Atrophy Coexistent with Occipital Periventricular White Matter Hyper Intensities
por: Duan, Dazhi, et al.
Publicado: (2016)

Have we been qualifying measurable residual disease correctly?
por: Feng, Yahui, et al.
Publicado: (2023)

Critical care - where have we been and where are we going?
por: Vincent, Jean-Louis
Publicado: (2013)

Craniofacial genetics: Where have we been and where are we going?
por: Weinberg, Seth M., et al.
Publicado: (2018)

Male contraception: where are we going and where have we been?
por: Reynolds-Wright, John Joseph, et al.
Publicado: (2019)

Telemedicine in Urology: Where Have We Been and Where Are We Heading?
por: Symeonidis, Evangelos N., et al.
Publicado: (2023)

Iron Deposition in Gray Matter Nuclei of Patients With Intracranial Artery Stenosis: A Quantitative Susceptibility Mapping Study
por: Mao, Huimin, et al.
Publicado: (2022)

Types of Descemet Membrane Detachment After Ocular Surface Burns: The Factor Long Been Ignored
por: Li, Yuan-Ting, et al.
Publicado: (2023)

Gray Matter Volume of Thalamic Nuclei in Traumatized North Korean Refugees
por: Lee, Jiye, et al.
Publicado: (2022)

Sequencing Technologies and Analyses: Where Have We Been and Where Are We Going?
por: Bansal, Vikas, et al.
Publicado: (2019)

Correction: Male contraception: where are we going and where have we been?
Publicado: (2020)

Depression in Diabetes: Have We Been Missing Something Important?
por: Gonzalez, Jeffrey S., et al.
Publicado: (2011)

Regional gray matter atrophy and neuropsychologcal problems in relapsing-remitting multiple sclerosis
por: Lin, Aiyu, et al.
Publicado: (2013)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Automated Steerable Path Planning for Deep Brain Stimulation Safeguarding Fiber Tracts and Deep Gray Matter Nuclei
por: Segato, Alice, et al.
Publicado: (2019)

Have we seen meson-exchanges in nuclei?
por: Frois, Bernard, et al.
Publicado: (1989)

Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping
por: Mao, Huimin, et al.
Publicado: (2022)

Biology Past and Biology Future: Where have we been and where are we going
Publicado: (2013)

Acute childhood leukemia in India: Where are we going, where have we been?
por: Kanwar, Vikramjit Singh
Publicado: (2016)

The ApoE Locus and COVID-19: Are We Going Where We Have Been?
por: Finch, Caleb E, et al.
Publicado: (2020)

Artificial intelligence in colonoscopy: where have we been and where should we go?
por: Mohan, Babu P., et al.
Publicado: (2023)

Gray matter atrophy rate as a marker of disease progression in AD
por: Anderson, Valerie M., et al.
Publicado: (2012)

The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis
por: Dupuy, Sheena L., et al.
Publicado: (2016)

Patterns of Cerebellar Gray Matter Atrophy Across Alzheimer’s Disease Progression
por: Toniolo, Sofia, et al.
Publicado: (2018)

Gray Matter Atrophy to Explain Subclinical Oculomotor Deficit in Multiple Sclerosis
por: Kincses, Bálint, et al.
Publicado: (2019)

Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization
por: De Stefano, Nicola, et al.
Publicado: (2021)

Have we been guilty of ageism in the primary treatment of breast cancer?
por: Pritchard, K I
Publicado: (2007)

Dupilumab for Atopic Dermatitis: The Silver Bullet We Have Been Searching for?
por: Tameez Ud Din, Ahsan, et al.
Publicado: (2020)

Spine Surgery Assisted by Augmented Reality: Where Have We Been?
por: Liu, Yanting, et al.
Publicado: (2022)

Articular Cartilage Repair: Where We Have Been, Where We Are Now, and Where We Are Headed
por: Grande, Daniel A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l1k3fnvgd3rivfjuu9nf34ipf8